Favicon of Revolution Medicines

Revolution Medicines

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Redwood City, United States of AmericaPharmaceuticals & BiotechEnterprise
Partnerships
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Clients
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Team
 

 

 
  
 

 

 
  
 

 

 
  

Share:

Company Details
Founded

2014
Employees

534

Similar to Revolution Medicines

Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  

Command Menu